29 studies found for: " July 23, 2008":" August 22, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Cognitive Behavioral Stress Management for HIV+ Drug Abusers
Women-Focused HIV Prevention in the Western Cape
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
† Study has passed its completion date and status has not been verified in more than two years.